Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis

Cara A. Rosenbaum, Umut Özbek, Larysa Sanchez, Jonathan Lagdameo, Alex Abrahams, Hani Hassoun, Oscar Lahoud, Ruben Niesvizky, Heather J. Landau, Keren Osman

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)5436-5439
Number of pages4
JournalBlood advances
Issue number18
StatePublished - 27 Sep 2022

Cite this